Recent News

• 12.02.2025 - Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 novembre 2025
• 12.02.2025 - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025
• 11.04.2025 - DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
• 11.04.2025 - DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation
• 11.03.2025 - DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer
• 11.03.2025 - DBV Technologies annonce la nomination de Kevin Trapp, dirigeant chevronné du secteur, au poste de Directeur Commercial
• 11.03.2025 - Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 octobre 2025
• 11.03.2025 - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of October 31, 2025
• 10.30.2025 - DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
• 10.30.2025 - DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration

Recent Filings

• 11.25.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.12.2025 - 3 Initial statement of beneficial ownership of securities
• 11.04.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 10.30.2025 - 8-K Current report